Robb Knie serves as Executive at Hoth Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Robb Knie has executed 7 insider transactions totaling $24.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 28, 2025 involved selling 310,744 shares valued at $376.0K.
Robb Knie currently holds 547,387 shares of Hoth Therapeutics, Inc. (HOTH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robb Knie has been a net buyer of HOTH stock. They have purchased $24.6K and sold $0 worth of shares.
Robb Knie's most recent insider trade was on Aug 28, 2025, when they sold 310,744 shares at $1.21 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 16, 2024 | HOTH | $16.8K | Purchase | 25,000 | $0.67 | Discretionary |
| Sep 19, 2022 | HOTH | $3.9K | Purchase | 10,000 | $0.39 | Discretionary |
| Sep 16, 2022 | HOTH | $4.0K | Purchase | 10,000 | $0.40 | Discretionary |
| May 18, 2020 | HOTH | $0 | Other | 4 | $N/A | Discretionary |
| Oct 28, 2019 | HOTH | $0 | Other | 85 | $N/A | Discretionary |